BHK

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Retrieved on: 
Thursday, March 28, 2024
Banking, Professional Services, Finance, Plan, BHK, FRA, BlackRock, Code, BBN, DSU, EGF, BGT, Fund, BLW

Shareholders should not draw any conclusions about a Fund’s investment performance from the amount of the Fund’s current distributions or from the terms of the Fund’s Plan.

Key Points: 
  • Shareholders should not draw any conclusions about a Fund’s investment performance from the amount of the Fund’s current distributions or from the terms of the Fund’s Plan.
  • BlackRock Enhanced Government Fund, Inc. (NYSE: EGF), BlackRock Debt Strategies Fund, Inc. (NYSE: DSU), BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE: FRA), BlackRock Floating Rate Income Trust (NYSE: BGT), BlackRock Corporate High Yield Fund, Inc. (NYSE: HYT), BlackRock Credit Allocation Income Trust (NYSE: BTZ), BlackRock Limited Duration Income Trust (NYSE: BLW), BlackRock Core Bond Trust (NYSE: BHK), BlackRock Multi-Sector Income Trust (NYSE: BIT), BlackRock Income Trust, Inc. (NYSE: BKT) and BlackRock Taxable Municipal Bond Trust (NYSE: BBN) have adopted a Plan to support a level monthly distribution of income, capital gains and/or return of capital.
  • The fixed amounts distributed per share are subject to change at the discretion of each Fund’s Board of Directors/Trustees.
  • Each Fund’s estimated sources of the distributions paid as of March 28, 2024 and for its current fiscal year are as follows:
    Estimated Allocations as of March 28, 2024

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Retrieved on: 
Thursday, February 29, 2024
Banking, Professional Services, Finance, EGF, Plan, Code, BHK, DSU, FRA, BBN, BlackRock, Fund, BLW, BGT

Shareholders should not draw any conclusions about a Fund’s investment performance from the amount of the Fund’s current distributions or from the terms of the Fund’s Plan.

Key Points: 
  • Shareholders should not draw any conclusions about a Fund’s investment performance from the amount of the Fund’s current distributions or from the terms of the Fund’s Plan.
  • BlackRock Enhanced Government Fund, Inc. (NYSE: EGF), BlackRock Debt Strategies Fund, Inc. (NYSE: DSU), BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE: FRA), BlackRock Floating Rate Income Trust (NYSE: BGT), BlackRock Corporate High Yield Fund, Inc. (NYSE: HYT), BlackRock Credit Allocation Income Trust (NYSE: BTZ), BlackRock Limited Duration Income Trust (NYSE: BLW), BlackRock Core Bond Trust (NYSE: BHK), BlackRock Multi-Sector Income Trust (NYSE: BIT), BlackRock Income Trust, Inc. (NYSE: BKT) and BlackRock Taxable Municipal Bond Trust (NYSE: BBN) have adopted a Plan to support a level monthly distribution of income, capital gains and/or return of capital.
  • The fixed amounts distributed per share are subject to change at the discretion of each Fund’s Board of Directors/Trustees.
  • Each Fund’s estimated sources of the distributions paid as of February 29, 2024 and for its current fiscal year are as follows:
    Estimated Allocations as of February 29, 2024

Ashwin Sheth Group presents its 15th iconic landmark in Kandivali, Mumbai - 'EDMONT Aurelia'

Retrieved on: 
Monday, December 4, 2023
Andheri, Aurelia, Process control block, BHK, School, Growth, Hospital, NRI, INR, Restaurant, Jodi, Kandivali

MUMBAI, India, Dec. 4, 2023 /PRNewswire/ -- Veteran real estate player, Ashwin Sheth Group, known for its luxury real estate developments in India, introduces its 15th milestone project in Kandivali West, 'EDMONT,' in Mumbai, India, along with a joint venture with K Hemani. Sprawled over 2.02 acres, EDMONT is a mixed-use development, 51-storey skyscraper integrating retail spaces, with EDMONT Aurelia as its first inaugural phase. Offering spacious 2 and 3 BHK flats along with Jodi flats (2 BHK + 2 BHK), starting from 761 Sq. Ft at INR 2.09 crores onwards, it presents an opportunity for luxurious living and astute investment in Mumbai's thriving real estate landscape.

Key Points: 
  • Offering spacious 2 and 3 BHK flats along with Jodi flats (2 BHK + 2 BHK), starting from 761 Sq.
  • Ft at INR 2.09 crores onwards, it presents an opportunity for luxurious living and astute investment in Mumbai's thriving real estate landscape.
  • Our latest project launch in Kandivali, Mumbai, and EDMONT Aurelia represents our vision to redefine Kandivali into a premier global destination.
  • Kandivali is located in the western suburbs of Mumbai, and it is one of the most preferred residential areas in Mumbai.

Sappi announces results for the third financial quarter 2023

Retrieved on: 
Thursday, August 3, 2023
Packaging, Environment, Forest Products, Manufacturing, Natural Resources, Textiles, Pressure, Somerset, Maintenance, Bleached Chemi-ThermoMechanical Pulp, Weakness, Share repurchase, EBITDA, BHK, DP, Verve, VSF, Paper, Growth, Sappi, Renminbi, Ngodwana, Pulp (paper), Retail, Cryptocurrency

Sappi delivered an EBITDA excluding special items of US$106 million against a backdrop of a challenging global economy and significantly weaker paper and pulp markets.

Key Points: 
  • Sappi delivered an EBITDA excluding special items of US$106 million against a backdrop of a challenging global economy and significantly weaker paper and pulp markets.
  • Net debt decreased by US$49 million from the prior quarter to US$1,176 million.
  • Continued weakness in graphic paper markets during the quarter was driven primarily by the destocking cycle and negative consumer sentiment.
  • Full details are available at www.sappi.com using the links Investors; Latest financial results

Cell Line Development Services Global Market Report 2022-2030: Increasing Trend of Biologics Outsourcing and Increasing Approval and Demand for Biologics and Biosimilars - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Health, Biotechnology, Raptr, Immortalised cell line, CHO, Geography, Sirna, Infection, N-Glycolylneuraminic acid, Growth, CLD, HEK, Therapy, BHK, Nanofluid, Degenerative disease, Research, CDMO, Incidence, CDO, GMP, Cell, Renewable energy, Vaccine, Fine chemical, Mobile phone, Hybridoma technology

The "Cell Line Development Services Global Market - Forecast To 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Line Development Services Global Market - Forecast To 2030" report has been added to ResearchAndMarkets.com's offering.
  • Increasing trend of biologics outsourcing and increasing approval and demand for biologics and biosimilars are driving the market.
  • Cell line development service global market is classified based on the expression system, cell line type, application and geography.
  • Based on expression system, cell line development service global market is segmented into microbial, mammalian and others.

Avirmax CMC Inc. Received License for cGMP Gene Therapy Vector Production by the California Department of Public Health

Retrieved on: 
Monday, October 31, 2022
Bayer, HEK293, AAV, Founder CEO, CDMO, California Department, Knowledge, CEO, Sf9, Contract manufacturing organization, CGMP, BHK, Public health, Technology, Drug development, SUB, A-DNA, DNA, DVM, Rita Raave, Therapy, CHO, Vaccine, Fine chemical, San Francisco Bay Area, Genentech

The facility has received cGMP license approval by the California Department of Public Health (CDPH)-Food & Drug Branch, for the production of rAAV drug products for use in clinical investigations.

Key Points: 
  • The facility has received cGMP license approval by the California Department of Public Health (CDPH)-Food & Drug Branch, for the production of rAAV drug products for use in clinical investigations.
  • The new cGMP facility will support us to deliver high yield and quality vectors efficiently, timely and cost effectively
    The new 20,000 sq.ft.
  • Production scales at 50L, 200L and 1000L, are available to customers depending on their clinical trial size and dose requirements.
  • With our new facility, Avirmax CMC Inc. is able to deliver high yield and quality vectors efficiently, timely and cost effectively.

Global Cell Line Development Market Outlook 2031: Increasing Risk of Pandemics and Communicable Diseases Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 27, 2022
Genetics, Health, Stem Cells, Cancer, Risk, BHK, CAGR, Industry, Chinese hamster ovary cell, CHO, USD, NSO, Cell, Coronavirus, Osteoporosis, Fine chemical

The "Global Cell Line Development Market Outlook 2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cell Line Development Market Outlook 2031" report has been added to ResearchAndMarkets.com's offering.
  • The global cell line development market is anticipated to grow with a CAGR of 12.39% over the forecast period, i.e., 2022 - 2031.
  • Additionally, the rising burden of osteoporosis, and also growing risk of coronavirus are expected to boost the market growth.
  • The global cell line development market is segmented into numerous segments which include segmentation by product, cell type, application, and by industry.

Insights on the Human Rabies Vaccines Global Market to 2027 - Lack of Management Services and Low Rate of Immunization in Pets is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Health, Infectious Diseases, Observation, Intravenous therapy, Global, Porter's five forces analysis, BHK, COVID-19, Risk, Administration, Geography, Growth, Ansoff Matrix, Market share, Industry, Market development, USD, Investment, Emotion, SWOT, Hospital pharmacy, Route of administration, CAGR, Marketing, Retail, Risk management, Vaccine

The report presents a detailed Ansoff matrix analysis for the Global Human Rabies Vaccines Market.

Key Points: 
  • The report presents a detailed Ansoff matrix analysis for the Global Human Rabies Vaccines Market.
  • The Global Human Rabies Vaccines Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Human Rabies Vaccines Market.
  • The Global Human Rabies Vaccines Market is segmented based on Cell Line Type, Route of Administration, Applications, Distribution Channel, and Geography.

The Worldwide Cell Culture Media Industry is Projected to Reach $10.3 Billion by 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 28, 2022
Health, Biotechnology, Risk, CAGR, Sartorius AG, USD, Merck Group, Growth, MEA, Stem cell, Research, Tissue engineering, BHK, Neutralizing antibody, Biopharmaceutical, LATAM, Cell biology, CHO, Danaher Corporation, Awareness, Corning Inc., Fine chemical, Vaccine, Biotechnology

The global cell culture media market is projected to USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026.

Key Points: 
  • The global cell culture media market is projected to USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026.
  • The serum-free media segment accounted for the highest growth rate in the cell culture media market, by type, during the forecast period
    In 2020, the serum-free media segment accounted for the largest share of the market.
  • Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US) are some of the major players operating in the cell culture media market.
  • The cell culture media market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA).

Panchshil Realty Logs Record Sales Across Its Residential Portfolio In Pune

Retrieved on: 
Friday, September 3, 2021
Steel, The Blackstone Group, BHK, Collection, Courtyard, Certification, Group, Trump Tower, Copper, Hospitality, Special economic zone, Architecture, Green building council, Procurement, Leadership, Commercial, YOO, Glass, Growth, Food, The Ritz-Carlton Hotel Company, Property management, Self storage, Hotel

PUNE, India, Sept. 3, 2021 /PRNewswire/ -- Panchshil Realty, one of India's leading luxury real estate developers today announced that it has logged one of its strongest years on record in the sales of its high-end residential portfolio of homes in Pune.

Key Points: 
  • Sharing his perspective on the strong sales uptick, Mr. Sagar Chordia, Director, Panchshil Realty said: "Over the last 18 months, we've seen phenomenal sales growth across our residential segment on the back of extremely strong demand from Mumbai.
  • "There is a very limited supply of ready-to-move-in premium homes with areas above 2000 square feet like Panchshil typically offers.
  • Panchshil Realty's total completed real estate portfolio is around 23 million square feet with another 20 million square feet under development.
  • A significant chunk of Panchshil Realty's office portfolio is anchored by Blackstone Real Estate Private Equity Fund, sponsored and managed by Blackstone Group LP.